tradingkey.logo

Avantor Inc

AVTR

12.710USD

+0.320+2.58%
Cierre 09/16, 16:00ETCotizaciones retrasadas 15 min
8.66BCap. mercado
12.60P/E TTM
Más Datos de Avantor Inc Compañía
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Información de la empresa
Símbolo de cotizaciónAVTR
Nombre de la empresaAvantor Inc
Fecha de salida a bolsaMay 17, 2019
Director ejecutivoMr. Emmanuel Ligner
Número de empleados13500
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 17
Dirección- -
Ciudad- -
Bolsa de valoresNYSE Consolidated
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónAVTR
Fecha de salida a bolsaMay 17, 2019
Director ejecutivoMr. Emmanuel Ligner
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
205.79K
+46.39%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Mr. Emmanuel Ligner
Mr. Emmanuel Ligner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
195.92K
--
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.56K
-0.11%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
52.07K
+48.89%
Ms. Lan Kang
Ms. Lan Kang
Independent Director
Independent Director
43.84K
+63.95%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Independent Director
Independent Director
39.83K
+75.24%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
205.79K
+46.39%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
201.96K
+416.65%
Mr. Emmanuel Ligner
Mr. Emmanuel Ligner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
195.92K
--
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.56K
-0.11%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Proprietary materials & consumables
829.70M
52.47%
Third party materials & consumables
751.70M
47.53%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Proprietary materials & consumables
829.70M
52.47%
Third party materials & consumables
751.70M
47.53%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dodge & Cox
17.23%
The Vanguard Group, Inc.
9.46%
T. Rowe Price Investment Management, Inc.
8.29%
BlackRock Institutional Trust Company, N.A.
8.19%
Barrow Hanley Global Investors
4.58%
Otro
52.26%
Accionistas
Accionistas
Proporción
Dodge & Cox
17.23%
The Vanguard Group, Inc.
9.46%
T. Rowe Price Investment Management, Inc.
8.29%
BlackRock Institutional Trust Company, N.A.
8.19%
Barrow Hanley Global Investors
4.58%
Otro
52.26%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.68%
Investment Advisor/Hedge Fund
39.88%
Hedge Fund
3.89%
Research Firm
2.20%
Private Equity
2.13%
Pension Fund
1.91%
Individual Investor
1.40%
Bank and Trust
1.36%
Sovereign Wealth Fund
1.26%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
1135
685.31M
100.52%
-76.76M
2025Q1
1158
711.07M
104.35%
-68.24M
2024Q4
1156
702.95M
103.24%
-73.39M
2024Q3
1145
700.88M
103.10%
-38.62M
2024Q2
1147
666.63M
98.14%
-52.63M
2024Q1
1136
657.58M
96.83%
-81.17M
2023Q4
1152
657.17M
97.18%
-48.15M
2023Q3
1143
643.33M
95.20%
-49.55M
2023Q2
1149
625.74M
92.71%
-61.95M
2023Q1
1138
629.07M
93.23%
-29.97M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dodge & Cox
100.26M
14.71%
+1.12M
+1.13%
Mar 31, 2025
The Vanguard Group, Inc.
64.63M
9.48%
+956.59K
+1.50%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
41.97M
6.16%
+608.81K
+1.47%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
56.00M
8.22%
+599.07K
+1.08%
Mar 31, 2025
Barrow Hanley Global Investors
30.26M
4.44%
-270.10K
-0.88%
Mar 31, 2025
State Street Global Advisors (US)
23.60M
3.46%
+290.54K
+1.25%
Mar 31, 2025
Manulife Investment Management (North America) Limited
14.03M
2.06%
+4.88M
+53.25%
Mar 31, 2025
New Mountain Capital, LLC
14.00M
2.05%
--
--
Mar 31, 2025
Clarkston Capital Partners, LLC
9.59M
1.41%
+1.45M
+17.75%
Mar 31, 2025
Geode Capital Management, L.L.C.
11.80M
1.73%
+564.11K
+5.02%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Otter Creek Focus Strategy ETF
3.07%
First Trust Health Care Alphadex Fund
1.5%
Invesco S&P MidCap Quality ETF
1.17%
John Hancock Fundamental All Cap Core ETF
1.14%
BNY Mellon Women's Opportunities ETF
0.88%
Nuveen ESG Mid-Cap Value ETF
0.86%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.67%
SPDR S&P 400 Mid Cap Value ETF
0.67%
First Trust Large Cap Value Alphadex Fund
0.59%
Pacer Lunt MidCap Multi-Factor Alternator ETF
0.56%
Ver más
Otter Creek Focus Strategy ETF
Proporción3.07%
First Trust Health Care Alphadex Fund
Proporción1.5%
Invesco S&P MidCap Quality ETF
Proporción1.17%
John Hancock Fundamental All Cap Core ETF
Proporción1.14%
BNY Mellon Women's Opportunities ETF
Proporción0.88%
Nuveen ESG Mid-Cap Value ETF
Proporción0.86%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proporción0.67%
SPDR S&P 400 Mid Cap Value ETF
Proporción0.67%
First Trust Large Cap Value Alphadex Fund
Proporción0.59%
Pacer Lunt MidCap Multi-Factor Alternator ETF
Proporción0.56%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI